Watson resolves Opana ER patent dispute with Endo Pharma
Endo Pharma has filed lawsuit on 4 March 2010, following Watson’s filing of an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) for
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.
The award is expected to fund preclinical studies, regulatory filings, manufacturing and clinical testing of Inviragen’s tetravalent dengue vaccine, DENVax delivered with PharmaJet’s convenient needle-free injection device. Inviragen